The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Assisted Reproductive Medications Market Research Report 2025
Synopsis
Assisted reproductive drugs include ovulation-stimulating drugs, luteal support drugs, down-regulatory drugs, ovulation-inducing drugs, etc. From the perspective of the use of various drugs in the IVF process, ovulation-stimulating drugs accounted for the highest proportion, as high as 62%, luteal support drugs accounted for 20%, down-regulatory drugs accounted for 15%, and ovulation-inducing drugs accounted for 3%.
The global Assisted Reproductive Medications market was valued at US$ 9472 million in 2023 and is anticipated to reach US$ 13290 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Assisted Reproductive Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Assisted Reproductive Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Assisted Reproductive Medications include Merck Serono, MSD, Livzon Pharmaceutical, Xianju Pharmaceutical and Kinsey Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Medications.
Report Scope
The Assisted Reproductive Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Assisted Reproductive Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Assisted Reproductive Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
MSD
Livzon Pharmaceutical
Xianju Pharmaceutical
Kinsey Pharmaceuticals
Segment by Type
Ovulation Stimulation Drugs
Luteal Support Medications
Downregulatory Drugs
Ovulation Inducing Drugs
Segment by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Assisted Reproductive Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Assisted Reproductive Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Assisted reproductive drugs include ovulation-stimulating drugs, luteal support drugs, down-regulatory drugs, ovulation-inducing drugs, etc. From the perspective of the use of various drugs in the IVF process, ovulation-stimulating drugs accounted for the highest proportion, as high as 62%, luteal support drugs accounted for 20%, down-regulatory drugs accounted for 15%, and ovulation-inducing drugs accounted for 3%.
The global Assisted Reproductive Medications market was valued at US$ 9472 million in 2023 and is anticipated to reach US$ 13290 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Assisted Reproductive Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Assisted Reproductive Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Assisted Reproductive Medications include Merck Serono, MSD, Livzon Pharmaceutical, Xianju Pharmaceutical and Kinsey Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Medications.
Report Scope
The Assisted Reproductive Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Assisted Reproductive Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Assisted Reproductive Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
MSD
Livzon Pharmaceutical
Xianju Pharmaceutical
Kinsey Pharmaceuticals
Segment by Type
Ovulation Stimulation Drugs
Luteal Support Medications
Downregulatory Drugs
Ovulation Inducing Drugs
Segment by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Assisted Reproductive Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Assisted Reproductive Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Assisted Reproductive Medications Market Overview
1.1 Product Overview and Scope of Assisted Reproductive Medications
1.2 Assisted Reproductive Medications Segment by Type
1.2.1 Global Assisted Reproductive Medications Market Value Comparison by Type (2024-2030)
1.2.2 Ovulation Stimulation Drugs
1.2.3 Luteal Support Medications
1.2.4 Downregulatory Drugs
1.2.5 Ovulation Inducing Drugs
1.3 Assisted Reproductive Medications Segment by Application
1.3.1 Global Assisted Reproductive Medications Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Assisted Reproductive Medications Market Size Estimates and Forecasts
1.4.1 Global Assisted Reproductive Medications Revenue 2019-2030
1.4.2 Global Assisted Reproductive Medications Sales 2019-2030
1.4.3 Global Assisted Reproductive Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Assisted Reproductive Medications Market Competition by Manufacturers
2.1 Global Assisted Reproductive Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Assisted Reproductive Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Assisted Reproductive Medications Average Price by Manufacturers (2019-2024)
2.4 Global Assisted Reproductive Medications Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Assisted Reproductive Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Assisted Reproductive Medications, Product Type & Application
2.7 Assisted Reproductive Medications Market Competitive Situation and Trends
2.7.1 Assisted Reproductive Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Assisted Reproductive Medications Players Market Share by Revenue
2.7.3 Global Assisted Reproductive Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Assisted Reproductive Medications Retrospective Market Scenario by Region
3.1 Global Assisted Reproductive Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Assisted Reproductive Medications Global Assisted Reproductive Medications Sales by Region: 2019-2030
3.2.1 Global Assisted Reproductive Medications Sales by Region: 2019-2024
3.2.2 Global Assisted Reproductive Medications Sales by Region: 2025-2030
3.3 Global Assisted Reproductive Medications Global Assisted Reproductive Medications Revenue by Region: 2019-2030
3.3.1 Global Assisted Reproductive Medications Revenue by Region: 2019-2024
3.3.2 Global Assisted Reproductive Medications Revenue by Region: 2025-2030
3.4 North America Assisted Reproductive Medications Market Facts & Figures by Country
3.4.1 North America Assisted Reproductive Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Assisted Reproductive Medications Sales by Country (2019-2030)
3.4.3 North America Assisted Reproductive Medications Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Assisted Reproductive Medications Market Facts & Figures by Country
3.5.1 Europe Assisted Reproductive Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Assisted Reproductive Medications Sales by Country (2019-2030)
3.5.3 Europe Assisted Reproductive Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Assisted Reproductive Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Assisted Reproductive Medications Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Assisted Reproductive Medications Sales by Country (2019-2030)
3.6.3 Asia Pacific Assisted Reproductive Medications Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Assisted Reproductive Medications Market Facts & Figures by Country
3.7.1 Latin America Assisted Reproductive Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Assisted Reproductive Medications Sales by Country (2019-2030)
3.7.3 Latin America Assisted Reproductive Medications Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Assisted Reproductive Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Assisted Reproductive Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Assisted Reproductive Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Assisted Reproductive Medications Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Assisted Reproductive Medications Sales by Type (2019-2030)
4.1.1 Global Assisted Reproductive Medications Sales by Type (2019-2024)
4.1.2 Global Assisted Reproductive Medications Sales by Type (2025-2030)
4.1.3 Global Assisted Reproductive Medications Sales Market Share by Type (2019-2030)
4.2 Global Assisted Reproductive Medications Revenue by Type (2019-2030)
4.2.1 Global Assisted Reproductive Medications Revenue by Type (2019-2024)
4.2.2 Global Assisted Reproductive Medications Revenue by Type (2025-2030)
4.2.3 Global Assisted Reproductive Medications Revenue Market Share by Type (2019-2030)
4.3 Global Assisted Reproductive Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Assisted Reproductive Medications Sales by Application (2019-2030)
5.1.1 Global Assisted Reproductive Medications Sales by Application (2019-2024)
5.1.2 Global Assisted Reproductive Medications Sales by Application (2025-2030)
5.1.3 Global Assisted Reproductive Medications Sales Market Share by Application (2019-2030)
5.2 Global Assisted Reproductive Medications Revenue by Application (2019-2030)
5.2.1 Global Assisted Reproductive Medications Revenue by Application (2019-2024)
5.2.2 Global Assisted Reproductive Medications Revenue by Application (2025-2030)
5.2.3 Global Assisted Reproductive Medications Revenue Market Share by Application (2019-2030)
5.3 Global Assisted Reproductive Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Corporation Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Assisted Reproductive Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Serono Assisted Reproductive Medications Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Corporation Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Assisted Reproductive Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 MSD Assisted Reproductive Medications Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 Livzon Pharmaceutical
6.3.1 Livzon Pharmaceutical Corporation Information
6.3.2 Livzon Pharmaceutical Description and Business Overview
6.3.3 Livzon Pharmaceutical Assisted Reproductive Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Livzon Pharmaceutical Assisted Reproductive Medications Product Portfolio
6.3.5 Livzon Pharmaceutical Recent Developments/Updates
6.4 Xianju Pharmaceutical
6.4.1 Xianju Pharmaceutical Corporation Information
6.4.2 Xianju Pharmaceutical Description and Business Overview
6.4.3 Xianju Pharmaceutical Assisted Reproductive Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Xianju Pharmaceutical Assisted Reproductive Medications Product Portfolio
6.4.5 Xianju Pharmaceutical Recent Developments/Updates
6.5 Kinsey Pharmaceuticals
6.5.1 Kinsey Pharmaceuticals Corporation Information
6.5.2 Kinsey Pharmaceuticals Description and Business Overview
6.5.3 Kinsey Pharmaceuticals Assisted Reproductive Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kinsey Pharmaceuticals Assisted Reproductive Medications Product Portfolio
6.5.5 Kinsey Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Assisted Reproductive Medications Industry Chain Analysis
7.2 Assisted Reproductive Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Assisted Reproductive Medications Production Mode & Process
7.4 Assisted Reproductive Medications Sales and Marketing
7.4.1 Assisted Reproductive Medications Sales Channels
7.4.2 Assisted Reproductive Medications Distributors
7.5 Assisted Reproductive Medications Customers
8 Assisted Reproductive Medications Market Dynamics
8.1 Assisted Reproductive Medications Industry Trends
8.2 Assisted Reproductive Medications Market Drivers
8.3 Assisted Reproductive Medications Market Challenges
8.4 Assisted Reproductive Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
